Category: Reagents

Filter By
Categories: Lipids Categories: RNA Clear all
(±)13-HpODE (±)13-HpODE

(±)13-HpODE

Reference: 10704-1
€0.00 (tax incl.)
A racemic mixture of hydroperoxides derived non-enzymatically from linoleic acid through the action of reactive oxygen species; has limited direct biological actions, such as the activation of lipoxygenases; normally...
(±)14(15)-DiHET (±)14(15)-DiHET

(±)14(15)-DiHET

Reference: 51651-50
€0.00 (tax incl.)
A urinary metabolite of (±)14(15)-EET which is elevated in pregnancy-induced hypertension
(±)14(15)-DiHET (±)14(15)-DiHET

(±)14(15)-DiHET

Reference: 51651-250
€0.00 (tax incl.)
A urinary metabolite of (±)14(15)-EET which is elevated in pregnancy-induced hypertension
(±)14(15)-DiHET (±)14(15)-DiHET

(±)14(15)-DiHET

Reference: 51651-25
€0.00 (tax incl.)
A urinary metabolite of (±)14(15)-EET which is elevated in pregnancy-induced hypertension
(±)14(15)-DiHET (±)14(15)-DiHET

(±)14(15)-DiHET

Reference: 51651-100
€0.00 (tax incl.)
A urinary metabolite of (±)14(15)-EET which is elevated in pregnancy-induced hypertension
(±)14(15)-DiHET MaxSpec® Standard (±)14(15)-DiHET MaxSpec® Standard

(±)14(15)-DiHET MaxSpec® Standard

Reference: 10007267-10
€0.00 (tax incl.)
A quantitative analytical standard guaranteed to meet MaxSpec® identity, purity, stability, and concentration specifications,
(±)14(15)-DiHETE (±)14(15)-DiHETE

(±)14(15)-DiHETE

Reference: 10006998-50
€0.00 (tax incl.)
An oxylipin and a metabolite of EPA; formed via cytochrome P450-mediated epoxidation of EPA to (±)14(15)-EpETE, followed by conversion of the epoxide to a diol by soluble epoxide hydrolase
(±)14(15)-DiHETE (±)14(15)-DiHETE

(±)14(15)-DiHETE

Reference: 10006998-25
€0.00 (tax incl.)
An oxylipin and a metabolite of EPA; formed via cytochrome P450-mediated epoxidation of EPA to (±)14(15)-EpETE, followed by conversion of the epoxide to a diol by soluble epoxide hydrolase
(±)14(15)-DiHETE (±)14(15)-DiHETE

(±)14(15)-DiHETE

Reference: 10006998-100
€0.00 (tax incl.)
An oxylipin and a metabolite of EPA; formed via cytochrome P450-mediated epoxidation of EPA to (±)14(15)-EpETE, followed by conversion of the epoxide to a diol by soluble epoxide hydrolase
(±)14(15)-EET (±)14(15)-EET

(±)14(15)-EET

Reference: 50651-500
€0.00 (tax incl.)
An arachidonic acid metabolite; formed via epoxidation of arachidonic acid by cytochrome P450; prevents increases in LTB4, ICAM-1, and CCL2 induced by oxidized LDL in primary RPAECs at 1 μM; induces dilation of...
(±)14(15)-EET (±)14(15)-EET

(±)14(15)-EET

Reference: 50651-50
€0.00 (tax incl.)
An arachidonic acid metabolite; formed via epoxidation of arachidonic acid by cytochrome P450; prevents increases in LTB4, ICAM-1, and CCL2 induced by oxidized LDL in primary RPAECs at 1 μM; induces dilation of...
(±)14(15)-EET (±)14(15)-EET

(±)14(15)-EET

Reference: 50651-25
€0.00 (tax incl.)
An arachidonic acid metabolite; formed via epoxidation of arachidonic acid by cytochrome P450; prevents increases in LTB4, ICAM-1, and CCL2 induced by oxidized LDL in primary RPAECs at 1 μM; induces dilation of...
(±)14(15)-EET (±)14(15)-EET

(±)14(15)-EET

Reference: 50651-100
€0.00 (tax incl.)
An arachidonic acid metabolite; formed via epoxidation of arachidonic acid by cytochrome P450; prevents increases in LTB4, ICAM-1, and CCL2 induced by oxidized LDL in primary RPAECs at 1 μM; induces dilation of...
(±)14(15)-EET Ethanolamide (±)14(15)-EET Ethanolamide

(±)14(15)-EET Ethanolamide

Reference: 10008599-50
€0.00 (tax incl.)
A racemic version of an epoxide produced by CYP450 metabolism of AEA
(±)14(15)-EET Ethanolamide (±)14(15)-EET Ethanolamide

(±)14(15)-EET Ethanolamide

Reference: 10008599-25
€0.00 (tax incl.)
A racemic version of an epoxide produced by CYP450 metabolism of AEA
(±)14(15)-EET Ethanolamide (±)14(15)-EET Ethanolamide

(±)14(15)-EET Ethanolamide

Reference: 10008599-100
€0.00 (tax incl.)
A racemic version of an epoxide produced by CYP450 metabolism of AEA
(±)14(15)-EET MaxSpec® Standard (±)14(15)-EET MaxSpec® Standard

(±)14(15)-EET MaxSpec® Standard

Reference: 10007263-100
€0.00 (tax incl.)
A quantitative analytical standard guaranteed to meet MaxSpec® identity, purity, stability, and concentration specifications,
(±)14(15)-EET methyl ester (±)14(15)-EET methyl ester

(±)14(15)-EET methyl ester

Reference: 50650-50
€0.00 (tax incl.)
An esterified version of (±)14(15)-EET; more stable for long-term storage and can be readily hydrolyzed to the free acid just before use; equipotent to (±)14(15)-EET in inducing relaxation of isolated bovine coronary...
(±)14(15)-EET methyl ester (±)14(15)-EET methyl ester

(±)14(15)-EET methyl ester

Reference: 50650-250
€0.00 (tax incl.)
An esterified version of (±)14(15)-EET; more stable for long-term storage and can be readily hydrolyzed to the free acid just before use; equipotent to (±)14(15)-EET in inducing relaxation of isolated bovine coronary...
(±)14(15)-EET methyl ester (±)14(15)-EET methyl ester

(±)14(15)-EET methyl ester

Reference: 50650-25
€0.00 (tax incl.)
An esterified version of (±)14(15)-EET; more stable for long-term storage and can be readily hydrolyzed to the free acid just before use; equipotent to (±)14(15)-EET in inducing relaxation of isolated bovine coronary...
(±)14(15)-EET methyl ester (±)14(15)-EET methyl ester

(±)14(15)-EET methyl ester

Reference: 50650-100
€0.00 (tax incl.)
An esterified version of (±)14(15)-EET; more stable for long-term storage and can be readily hydrolyzed to the free acid just before use; equipotent to (±)14(15)-EET in inducing relaxation of isolated bovine coronary...
(±)14(15)-EET-SI (±)14(15)-EET-SI

(±)14(15)-EET-SI

Reference: 10009286-50
€0.00 (tax incl.)
A metabolically stable methyl sulfonamide analog of 14(15)-EET; equipotent to 14(15)-EET in vascular agonist activity
(±)14(15)-EET-SI (±)14(15)-EET-SI

(±)14(15)-EET-SI

Reference: 10009286-25
€0.00 (tax incl.)
A metabolically stable methyl sulfonamide analog of 14(15)-EET; equipotent to 14(15)-EET in vascular agonist activity
(±)14(15)-EET-SI (±)14(15)-EET-SI

(±)14(15)-EET-SI

Reference: 10009286-100
€0.00 (tax incl.)
A metabolically stable methyl sulfonamide analog of 14(15)-EET; equipotent to 14(15)-EET in vascular agonist activity
(±)14(15)-EpEDE (±)14(15)-EpEDE

(±)14(15)-EpEDE

Reference: 10007527-500
€0.00 (tax incl.)
An EpEDE acid formed from DGLA, either by a strong oxidizing agent or by cytochrome P450 epoxygenases; biological properties are poorly understood
(±)14(15)-EpEDE (±)14(15)-EpEDE

(±)14(15)-EpEDE

Reference: 10007527-50
€0.00 (tax incl.)
An EpEDE acid formed from DGLA, either by a strong oxidizing agent or by cytochrome P450 epoxygenases; biological properties are poorly understood
(±)14(15)-EpEDE (±)14(15)-EpEDE

(±)14(15)-EpEDE

Reference: 10007527-25
€0.00 (tax incl.)
An EpEDE acid formed from DGLA, either by a strong oxidizing agent or by cytochrome P450 epoxygenases; biological properties are poorly understood
(±)14(15)-EpEDE (±)14(15)-EpEDE

(±)14(15)-EpEDE

Reference: 10007527-100
€0.00 (tax incl.)
An EpEDE acid formed from DGLA, either by a strong oxidizing agent or by cytochrome P450 epoxygenases; biological properties are poorly understood
(±)14(15)-EpEDE methyl ester (±)14(15)-EpEDE methyl ester

(±)14(15)-EpEDE methyl ester

Reference: 10007528-500
€0.00 (tax incl.)
An analog of (±)14(15)-EpEDE with greater lipid solubility than the free base
(±)14(15)-EpEDE methyl ester (±)14(15)-EpEDE methyl ester

(±)14(15)-EpEDE methyl ester

Reference: 10007528-50
€0.00 (tax incl.)
An analog of (±)14(15)-EpEDE with greater lipid solubility than the free base
(±)14(15)-EpEDE methyl ester (±)14(15)-EpEDE methyl ester

(±)14(15)-EpEDE methyl ester

Reference: 10007528-25
€0.00 (tax incl.)
An analog of (±)14(15)-EpEDE with greater lipid solubility than the free base
(±)14(15)-EpEDE methyl ester (±)14(15)-EpEDE methyl ester

(±)14(15)-EpEDE methyl ester

Reference: 10007528-100
€0.00 (tax incl.)
An analog of (±)14(15)-EpEDE with greater lipid solubility than the free base
(±)14(15)-EpETE (±)14(15)-EpETE

(±)14(15)-EpETE

Reference: 10173-500
€0.00 (tax incl.)
EDHF is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (NO) and COX-derived (prostacyclin) vasodilators.(6485,7204) CYP450...
(±)14(15)-EpETE (±)14(15)-EpETE

(±)14(15)-EpETE

Reference: 10173-50
€0.00 (tax incl.)
EDHF is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (NO) and COX-derived (prostacyclin) vasodilators.(6485,7204) CYP450...
(±)14(15)-EpETE (±)14(15)-EpETE

(±)14(15)-EpETE

Reference: 10173-25
€0.00 (tax incl.)
EDHF is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (NO) and COX-derived (prostacyclin) vasodilators.(6485,7204) CYP450...
(±)14(15)-EpETE (±)14(15)-EpETE

(±)14(15)-EpETE

Reference: 10173-100
€0.00 (tax incl.)
EDHF is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (NO) and COX-derived (prostacyclin) vasodilators.(6485,7204) CYP450...
(±)14-HDHA (±)14-HDHA

(±)14-HDHA

Reference: 33550-250
€0.00 (tax incl.)
(±)14-HDHA is an autoxidation product of DHA in vitro.(7479,7491) It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.(7480,7490,7492) DHA is metabolized to 14(S)-HDHA by human...
(±)14-HDHA (±)14-HDHA

(±)14-HDHA

Reference: 33550-100
€0.00 (tax incl.)
(±)14-HDHA is an autoxidation product of DHA in vitro.(7479,7491) It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.(7480,7490,7492) DHA is metabolized to 14(S)-HDHA by human...
(±)14-HDHA (±)14-HDHA

(±)14-HDHA

Reference: 33550-50
€0.00 (tax incl.)
(±)14-HDHA is an autoxidation product of DHA in vitro.(7479,7491) It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.(7480,7490,7492) DHA is metabolized to 14(S)-HDHA by human...
(±)14-HDHA (±)14-HDHA

(±)14-HDHA

Reference: 33550-25
€0.00 (tax incl.)
(±)14-HDHA is an autoxidation product of DHA in vitro.(7479,7491) It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.(7480,7490,7492) DHA is metabolized to 14(S)-HDHA by human...
(±)15-HEDE (±)15-HEDE

(±)15-HEDE

Reference: 37700-50
€0.00 (tax incl.)
(±)15-HEDE is produced by non-enzymatic oxidation of 11,14-eicosadienoic acid. The biological activity of (±)15-HEDE has not been clearly documented.
(±)15-HEDE (±)15-HEDE

(±)15-HEDE

Reference: 37700-250
€0.00 (tax incl.)
(±)15-HEDE is produced by non-enzymatic oxidation of 11,14-eicosadienoic acid. The biological activity of (±)15-HEDE has not been clearly documented.
(±)15-HEDE (±)15-HEDE

(±)15-HEDE

Reference: 37700-25
€0.00 (tax incl.)
(±)15-HEDE is produced by non-enzymatic oxidation of 11,14-eicosadienoic acid. The biological activity of (±)15-HEDE has not been clearly documented.
(±)15-HEDE (±)15-HEDE

(±)15-HEDE

Reference: 37700-100
€0.00 (tax incl.)
(±)15-HEDE is produced by non-enzymatic oxidation of 11,14-eicosadienoic acid. The biological activity of (±)15-HEDE has not been clearly documented.
(±)15-HEPE (±)15-HEPE

(±)15-HEPE

Reference: 32700-50
€0.00 (tax incl.)
(±)15-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 15(S)-HEPE and 15(R)-HEPE. Specific biological activity attributed to (±)15-HEPE has not been documented.
(±)15-HEPE (±)15-HEPE

(±)15-HEPE

Reference: 32700-25
€0.00 (tax incl.)
(±)15-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 15(S)-HEPE and 15(R)-HEPE. Specific biological activity attributed to (±)15-HEPE has not been documented.
(±)15-HEPE (±)15-HEPE

(±)15-HEPE

Reference: 32700-100
€0.00 (tax incl.)
(±)15-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 15(S)-HEPE and 15(R)-HEPE. Specific biological activity attributed to (±)15-HEPE has not been documented.
(±)15-HETE (±)15-HETE

(±)15-HETE

Reference: 34700-50
€0.00 (tax incl.)
(±)15-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)15-HETE is similar to that of its constituent enantiomers (Item Nos....
(±)15-HETE (±)15-HETE

(±)15-HETE

Reference: 34700-250
€0.00 (tax incl.)
(±)15-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)15-HETE is similar to that of its constituent enantiomers (Item Nos....
(±)15-HETE (±)15-HETE

(±)15-HETE

Reference: 34700-25
€0.00 (tax incl.)
(±)15-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)15-HETE is similar to that of its constituent enantiomers (Item Nos....
(±)15-HETE (±)15-HETE

(±)15-HETE

Reference: 34700-100
€0.00 (tax incl.)
(±)15-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)15-HETE is similar to that of its constituent enantiomers (Item Nos....
(±)16(17)-DiHDPA (±)16(17)-DiHDPA

(±)16(17)-DiHDPA

Reference: 18176-500
€0.00 (tax incl.)
A DHA metabolite that inhibits VEGF-induced angiogenesis and reduces cancer cell metastasis in mice
(±)16(17)-DiHDPA (±)16(17)-DiHDPA

(±)16(17)-DiHDPA

Reference: 18176-50
€0.00 (tax incl.)
A DHA metabolite that inhibits VEGF-induced angiogenesis and reduces cancer cell metastasis in mice
(±)16(17)-DiHDPA (±)16(17)-DiHDPA

(±)16(17)-DiHDPA

Reference: 18176-100
€0.00 (tax incl.)
A DHA metabolite that inhibits VEGF-induced angiogenesis and reduces cancer cell metastasis in mice
(±)16(17)-DiHDPA (±)16(17)-DiHDPA

(±)16(17)-DiHDPA

Reference: 18176-1
€0.00 (tax incl.)
A DHA metabolite that inhibits VEGF-induced angiogenesis and reduces cancer cell metastasis in mice
(±)16(17)-EpDPA (±)16(17)-EpDPA

(±)16(17)-EpDPA

Reference: 10174-500
€0.00 (tax incl.)
A DHA metabolite derived via epoxidation of the 16,17-double bond; epoxygenase metabolites of DHA have been detected in a mouse model of inflammation
(±)16(17)-EpDPA (±)16(17)-EpDPA

(±)16(17)-EpDPA

Reference: 10174-50
€0.00 (tax incl.)
A DHA metabolite derived via epoxidation of the 16,17-double bond; epoxygenase metabolites of DHA have been detected in a mouse model of inflammation
(±)16(17)-EpDPA (±)16(17)-EpDPA

(±)16(17)-EpDPA

Reference: 10174-25
€0.00 (tax incl.)
A DHA metabolite derived via epoxidation of the 16,17-double bond; epoxygenase metabolites of DHA have been detected in a mouse model of inflammation
(±)16(17)-EpDPA (±)16(17)-EpDPA

(±)16(17)-EpDPA

Reference: 10174-100
€0.00 (tax incl.)
A DHA metabolite derived via epoxidation of the 16,17-double bond; epoxygenase metabolites of DHA have been detected in a mouse model of inflammation
(±)16-HDHA (±)16-HDHA

(±)16-HDHA

Reference: 33600-50
€0.00 (tax incl.)
(±)16-HDHA is an autoxidation product of DHA in vitro.(7479,7491) It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.(7480,7490,7492) (±)16-HDHA is a potential marker of...
(±)16-HDHA (±)16-HDHA

(±)16-HDHA

Reference: 33600-250
€0.00 (tax incl.)
(±)16-HDHA is an autoxidation product of DHA in vitro.(7479,7491) It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.(7480,7490,7492) (±)16-HDHA is a potential marker of...
(±)16-HDHA (±)16-HDHA

(±)16-HDHA

Reference: 33600-25
€0.00 (tax incl.)
(±)16-HDHA is an autoxidation product of DHA in vitro.(7479,7491) It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.(7480,7490,7492) (±)16-HDHA is a potential marker of...
(±)16-HDHA (±)16-HDHA

(±)16-HDHA

Reference: 33600-100
€0.00 (tax incl.)
(±)16-HDHA is an autoxidation product of DHA in vitro.(7479,7491) It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.(7480,7490,7492) (±)16-HDHA is a potential marker of...
(±)16-HETE (±)16-HETE

(±)16-HETE

Reference: 10010635-50
€0.00 (tax incl.)
The racemic version of a minor CYP450 metabolite of arachidonic acid with stereospecific effects on renal function; 16(R)-HETE dose-dependently stimulates vasodilation of the rabbit kidney while 16(S)-HETE potently...
(±)16-HETE (±)16-HETE

(±)16-HETE

Reference: 10010635-25
€0.00 (tax incl.)
The racemic version of a minor CYP450 metabolite of arachidonic acid with stereospecific effects on renal function; 16(R)-HETE dose-dependently stimulates vasodilation of the rabbit kidney while 16(S)-HETE potently...
(±)16-HETE (±)16-HETE

(±)16-HETE

Reference: 10010635-100
€0.00 (tax incl.)
The racemic version of a minor CYP450 metabolite of arachidonic acid with stereospecific effects on renal function; 16(R)-HETE dose-dependently stimulates vasodilation of the rabbit kidney while 16(S)-HETE potently...
(±)17(18)-DiHETE (±)17(18)-DiHETE

(±)17(18)-DiHETE

Reference: 10006999-50
€0.00 (tax incl.)
EPA is an ω-3 fatty acid abundantly available in marine organisms. (±)17(18)-DiHETE is one of the major metabolites produced when EPA is incubated with various rat tissue homogenates or cynomolgus monkey seminal...
(±)17(18)-DiHETE (±)17(18)-DiHETE

(±)17(18)-DiHETE

Reference: 10006999-25
€0.00 (tax incl.)
EPA is an ω-3 fatty acid abundantly available in marine organisms. (±)17(18)-DiHETE is one of the major metabolites produced when EPA is incubated with various rat tissue homogenates or cynomolgus monkey seminal...
(±)17(18)-DiHETE (±)17(18)-DiHETE

(±)17(18)-DiHETE

Reference: 10006999-100
€0.00 (tax incl.)
EPA is an ω-3 fatty acid abundantly available in marine organisms. (±)17(18)-DiHETE is one of the major metabolites produced when EPA is incubated with various rat tissue homogenates or cynomolgus monkey seminal...
(±)17(18)-EpETE methyl ester (±)17(18)-EpETE methyl ester

(±)17(18)-EpETE methyl ester

Reference: 13367-500
€0.00 (tax incl.)
An esterified form of (±)17(18)-EpETE; more lipid soluble than (±)17(18)-EpETE
(±)17(18)-EpETE methyl ester (±)17(18)-EpETE methyl ester

(±)17(18)-EpETE methyl ester

Reference: 13367-50
€0.00 (tax incl.)
An esterified form of (±)17(18)-EpETE; more lipid soluble than (±)17(18)-EpETE
(±)17(18)-EpETE methyl ester (±)17(18)-EpETE methyl ester

(±)17(18)-EpETE methyl ester

Reference: 13367-25
€0.00 (tax incl.)
An esterified form of (±)17(18)-EpETE; more lipid soluble than (±)17(18)-EpETE
(±)17(18)-EpETE methyl ester (±)17(18)-EpETE methyl ester

(±)17(18)-EpETE methyl ester

Reference: 13367-100
€0.00 (tax incl.)
An esterified form of (±)17(18)-EpETE; more lipid soluble than (±)17(18)-EpETE
(±)17(18)-EpETE-Ethanolamide (±)17(18)-EpETE-Ethanolamide

(±)17(18)-EpETE-Ethanolamide

Reference: 25920-500
€0.00 (tax incl.)
An ω-3 endocannabinoid epoxide; decreases LPS-induced IL-6 and nitrite production and increases the production of IL-10 in BV-2 microglia; inhibits arachidonic acid-induced platelet aggregation at 50 µM; induces...
(±)17(18)-EpETE-Ethanolamide (±)17(18)-EpETE-Ethanolamide

(±)17(18)-EpETE-Ethanolamide

Reference: 25920-50
€0.00 (tax incl.)
An ω-3 endocannabinoid epoxide; decreases LPS-induced IL-6 and nitrite production and increases the production of IL-10 in BV-2 microglia; inhibits arachidonic acid-induced platelet aggregation at 50 µM; induces...
(±)17(18)-EpETE-Ethanolamide (±)17(18)-EpETE-Ethanolamide

(±)17(18)-EpETE-Ethanolamide

Reference: 25920-25
€0.00 (tax incl.)
An ω-3 endocannabinoid epoxide; decreases LPS-induced IL-6 and nitrite production and increases the production of IL-10 in BV-2 microglia; inhibits arachidonic acid-induced platelet aggregation at 50 µM; induces...
(±)17(18)-EpETE-Ethanolamide (±)17(18)-EpETE-Ethanolamide

(±)17(18)-EpETE-Ethanolamide

Reference: 25920-100
€0.00 (tax incl.)
An ω-3 endocannabinoid epoxide; decreases LPS-induced IL-6 and nitrite production and increases the production of IL-10 in BV-2 microglia; inhibits arachidonic acid-induced platelet aggregation at 50 µM; induces...
(±)17-HDHA (±)17-HDHA

(±)17-HDHA

Reference: 33650-50
€0.00 (tax incl.)
(±)17-HDHA is an autoxidation product of DHA in vitro.(7479,7491) It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.(7480,7490,7492) 17(S)-HDHA can be produced by enzymatic...
(±)17-HDHA (±)17-HDHA

(±)17-HDHA

Reference: 33650-250
€0.00 (tax incl.)
(±)17-HDHA is an autoxidation product of DHA in vitro.(7479,7491) It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.(7480,7490,7492) 17(S)-HDHA can be produced by enzymatic...
(±)17-HDHA (±)17-HDHA

(±)17-HDHA

Reference: 33650-25
€0.00 (tax incl.)
(±)17-HDHA is an autoxidation product of DHA in vitro.(7479,7491) It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.(7480,7490,7492) 17(S)-HDHA can be produced by enzymatic...
(±)17-HDHA (±)17-HDHA

(±)17-HDHA

Reference: 33650-100
€0.00 (tax incl.)
(±)17-HDHA is an autoxidation product of DHA in vitro.(7479,7491) It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.(7480,7490,7492) 17(S)-HDHA can be produced by enzymatic...
(±)17-HDHA MaxSpec® Standard (±)17-HDHA MaxSpec® Standard

(±)17-HDHA MaxSpec® Standard

Reference: 10007223-100
€0.00 (tax incl.)
A quantitative analytical standard guaranteed to meet MaxSpec® identity, purity, stability, and concentration specifications,
(±)17-HETE (±)17-HETE

(±)17-HETE

Reference: 10010636-50
€0.00 (tax incl.)
The racemic version of a CYP450 metabolite of arachidonic acid that potently inhibits proximal tubule ATPase activity.
(±)17-HETE (±)17-HETE

(±)17-HETE

Reference: 10010636-25
€0.00 (tax incl.)
The racemic version of a CYP450 metabolite of arachidonic acid that potently inhibits proximal tubule ATPase activity.
(±)17-HETE (±)17-HETE

(±)17-HETE

Reference: 10010636-100
€0.00 (tax incl.)
The racemic version of a CYP450 metabolite of arachidonic acid that potently inhibits proximal tubule ATPase activity.
(±)18-HEPE (±)18-HEPE

(±)18-HEPE

Reference: 32840-50
€0.00 (tax incl.)
A non-enzymatic oxidation product of EPA; increased in the plasma and heart, as well as in the supernatant of cultured peritoneal macrophages isolated from fat-1 transgenic mice; reduces increases in cardiac fibrosis...
(±)18-HEPE (±)18-HEPE

(±)18-HEPE

Reference: 32840-250
€0.00 (tax incl.)
A non-enzymatic oxidation product of EPA; increased in the plasma and heart, as well as in the supernatant of cultured peritoneal macrophages isolated from fat-1 transgenic mice; reduces increases in cardiac fibrosis...
(±)18-HEPE (±)18-HEPE

(±)18-HEPE

Reference: 32840-25
€0.00 (tax incl.)
A non-enzymatic oxidation product of EPA; increased in the plasma and heart, as well as in the supernatant of cultured peritoneal macrophages isolated from fat-1 transgenic mice; reduces increases in cardiac fibrosis...
(±)18-HEPE (±)18-HEPE

(±)18-HEPE

Reference: 32840-100
€0.00 (tax incl.)
A non-enzymatic oxidation product of EPA; increased in the plasma and heart, as well as in the supernatant of cultured peritoneal macrophages isolated from fat-1 transgenic mice; reduces increases in cardiac fibrosis...
(±)18-HETE (±)18-HETE

(±)18-HETE

Reference: 10010638-50
€0.00 (tax incl.)
The racemic version of a CYP450 metabolite of arachidonic acid that dose-dependently stimulates vasodilation of the rabbit kidney
(±)18-HETE (±)18-HETE

(±)18-HETE

Reference: 10010638-25
€0.00 (tax incl.)
The racemic version of a CYP450 metabolite of arachidonic acid that dose-dependently stimulates vasodilation of the rabbit kidney
(±)18-HETE (±)18-HETE

(±)18-HETE

Reference: 10010638-100
€0.00 (tax incl.)
The racemic version of a CYP450 metabolite of arachidonic acid that dose-dependently stimulates vasodilation of the rabbit kidney
(±)19(20)-DiHDPA (±)19(20)-DiHDPA

(±)19(20)-DiHDPA

Reference: 10007001-500
€0.00 (tax incl.)
(±)19(20)-DiHDPA is one of the major metabolites produced when DHA is incubated with NADPH-supplemented rat liver microsomes; formed by the slow metabolism of DHA by monkey seminal vesicles
(±)19(20)-DiHDPA (±)19(20)-DiHDPA

(±)19(20)-DiHDPA

Reference: 10007001-50
€0.00 (tax incl.)
(±)19(20)-DiHDPA is one of the major metabolites produced when DHA is incubated with NADPH-supplemented rat liver microsomes; formed by the slow metabolism of DHA by monkey seminal vesicles
(±)19(20)-DiHDPA (±)19(20)-DiHDPA

(±)19(20)-DiHDPA

Reference: 10007001-100
€0.00 (tax incl.)
(±)19(20)-DiHDPA is one of the major metabolites produced when DHA is incubated with NADPH-supplemented rat liver microsomes; formed by the slow metabolism of DHA by monkey seminal vesicles
(±)19(20)-DiHDPA (±)19(20)-DiHDPA

(±)19(20)-DiHDPA

Reference: 10007001-1
€0.00 (tax incl.)
(±)19(20)-DiHDPA is one of the major metabolites produced when DHA is incubated with NADPH-supplemented rat liver microsomes; formed by the slow metabolism of DHA by monkey seminal vesicles
(±)19(20)-EDP Ethanolamide (±)19(20)-EDP Ethanolamide

(±)19(20)-EDP Ethanolamide

Reference: 25917-500
€0.00 (tax incl.)
An ω-3 endocannabinoid epoxide and CB receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively); reduces the viability of 143B metastatic osteosarcoma cells at 25 µM; decreases the production of IL-6 and...

Menu

Settings

Please sign in first.

Sign in